Tier 2 — strong
Validation of two point-of-care tests against standard lab measures of NO in saliva and in serum
Nitric Oxide
2017
64:16–21
Bibliography
- PubMed
- PMID 28153714
- PubMed Central
- PMC5569892
- Funding
- Not yet independently verified for this record
- Competing interests
- Not yet independently verified for this record
Study snapshot
| Design | Cross-sectional validation against laboratory assays |
|---|---|
| Model | 20 non-smoking overweight or obese adults, ages 40–65 |
| Sample | 20 non-smoking overweight or obese adults aged 40–65 |
| Intervention | Commercial salivary nitrite test strips compared with lab saliva and serum nitrite/nitrate assays |
| Duration | Cross-sectional baseline sample; no long-term supplementation intervention |
| Endpoints | Correlations with laboratory salivary and systemic nitrate/nitrite measurements |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Low Nitric Oxide: Causes, Symptoms and Tests ExplainedCan you have low nitric oxide? Understand endothelial dysfunction, nonspecific symptoms, vascular risks, saliva-strip limitations and when to seek care.Read analysis
- Nitralis Clinical Trial: Results, Limitations and Dose DifferencesAn evidence-based analysis of the 85-person, 30-day Nitralis trial: actual test-strip results, study dose, funding, limitations and unresolved clinical questions.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
